Production of pharmaceutical intermediates and specialty chemicals in India.
Annual revenue $8.8M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Connex Pharma

Connex Pharma is a company. Connex Pharma offers products and services including Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC).

  • Sectors
    Chemicals & Materials
  • Email
    ***********
  • Phone
    *********
  • Social
    *********
  • Legal Name Connex Pharma Private Ltd
  • Jurisdiction Vishakapatnam, Andhra Pradesh, India
Operational Areas
Chemicals & Materials → Polymers, Plastics & Petrochemicals
Key Metrics
  • Annual Revenue
    $8.79 M (USD)
    146.59
    as on Mar 31, 2022
  • Net Profit
    $350.73 K (USD)
    5.21
    as on Mar 31, 2022
  • EBITDA
    $3.09 M (USD)
    59.81
    as on Mar 31, 2022
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Connex Pharma

Connex Pharma offers a comprehensive portfolio of products and services, including Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC).

Primary

It is produced as a versatile organosilicon compound that is utilized in various applications.

It is employed in the production process of antiviral medications like Tenofovir.

Funding Insights of Connex Pharma

Investments & Acquisitions by Connex Pharma

Investments

Financial Statements - Connex Pharma

Connex Pharma Comparisons

+
Add Comparison
Available on Premium

Competitors of Connex Pharma

Latest news on Connex Pharma

Frequently Asked Questions about Connex Pharma

Annual revenue of Connex Pharma is $8.79M as on Mar 31, 2022.

Connex Pharma is operated as a manufacturer of pharmaceutical intermediates from a 5.4-acre facility in Vishakhapatnam, Andhra Pradesh, with certifications under ISO 9001:2015 and ISO 14001:2015. Specialty chemicals like Hexamethyldisilazane and Chloromethyl Isopropyl Carbonate are produced using state-of-the-art instruments, while adherence to Good Manufacturing Practices is maintained for secure processes. The company is also registered with D-U-N-S and serves global markets through its network, ensuring reliable operations in the chemicals sector. A focus on safe production methods is evident in its activities.

Connex Pharma offers Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available